Address : Lausanne, Vaud 1003, Switzerland
Phone Number : +41 21 693 8242
Industries : Research, Biotechnology
Website : asceneuron.com
Company Description
Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer's and Parkinson's disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson's Disease, Alzheimer's disease and related disorders.Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Kurma Partners. For more information, please visit www.asceneuron.com.Further information: www.asceneuron.com
Specialities
- Orphan Diseases
- Alzheimers Disease
- Neurodegeneration
- Psp
- Biotechnology
- Biotechnology Research
- Tauopathies
- Small Molecule Drug Discovery
- Novel Therapeutics
- Parkinsons Disease
- Research
Financial
Employees Total : 10
Revenue (Yearly) : 8.9M
Total Funding : 37.7M
Latest Funding : 2.2M
Miscellaneous
Founded in : 2012
Twitter : asceneuron_sa
Linkedin : asceneuron-sa
Email Providers : Outlook
CSS and JavaScript Libraries : Bootstrap Framework
Fonts : Google Font API
Captcha : reCAPTCHA
Load Balancers : Apache
Tech : Mobile Friendly
Last Updated : 2023-11-19
You Might Be Interested With:
 | Ace Engineers Inc Haddonfield, New Jersey, United States Construction |
 | Arbor Builders Bend, Oregon, United States |
 | ARTCONSULTING Balbach Berlin Berlin, Germany Management Consulting |
| | Aussie Living Virginia, Queensland, Australia Furniture |
| | Dierckx, Luc Mol, Flanders, Belgium |
| | DISTRIBUZIONE GOLD S.R.L. Cosenza, Calabria, Italy Retail |